Improvement of the clinical outcome in patients with resectable pancreatic carcinoma through
an intensified adjuvant treatment with gemcitabine, cisplatin and regional deep hyperthermia
as compared to standard chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Klinikum der Universitaet Muenchen, Grosshadern
Collaborators:
Ludwig-Maximilians - University of Munich The European Society for Hyperthermic Oncology